What are the treatment options for locally advanced Stomach Cancer

Treatment Options for Locally Advanced Stomach Cancer

Based on current medical guidelines, locally advanced stomach cancer (cancer that has grown into deeper layers of the stomach wall and/or nearby lymph nodes, but hasn't spread to distant organs) has several treatment approaches. Let me walk you through how doctors think about this and what options typically exist.

How Doctors Approach Locally Advanced Stomach Cancer

According to NCCN Guidelines for Gastric Cancer, the treatment strategy depends on whether the cancer can be surgically removed (resectable) and whether the patient is medically able to tolerate major surgery. The key principle is perioperative systemic therapy — meaning chemotherapy or immunotherapy given around the time of surgery to shrink the tumor and eliminate microscopic disease.

---

General Treatment Approaches

1. Perioperative Systemic Therapy + Surgery (Category 1 Recommendation)

This is the preferred approach for most patients with locally advanced, resectable stomach cancer:

What this means: Chemotherapy is given BEFORE surgery (neoadjuvant therapy) to shrink the tumor, making surgery more effective. After surgery, additional chemotherapy may continue.

• Timing: Chemotherapy typically starts first, followed by surgery about 5-8 weeks later, then additional chemotherapy afterward
• Goal: Reduce tumor size, eliminate cancer cells that may have spread microscopically, and improve surgical outcomes

2. Immunotherapy Consideration for Specific Tumor Types

If your tumor has specific genetic features (MSI-H or dMMR — meaning mismatch repair deficiency), NCCN Guidelines recommend considering perioperative immunotherapy (immune checkpoint inhibitors) in consultation with your multidisciplinary team. This is an emerging approach that harnesses your immune system to fight cancer.

3. Surgery as Primary Treatment

For certain situations (early-stage cancers ≥T1b, actively bleeding cancers, or when patients prefer surgery first), surgery may be performed first, followed by post-operative chemotherapy or chemoradiation.

4. Chemoradiation for Unresectable Disease

If surgery isn't possible due to tumor location or patient health, fluoropyrimidine-based chemoradiation (combining chemotherapy with radiation therapy) is recommended to control local disease.

---

What Happens After Initial Treatment

According to NCCN Guidelines, after surgery and systemic therapy, your care team will:

• Assess response with imaging (CT scan, PET scan, or endoscopy) about 5-8 weeks after completing pre-operative therapy
• Determine next steps based on findings:
  • No evidence of disease: Observation with follow-up imaging
  • Persistent local disease: May consider additional surgery or chemoradiation
  • New metastatic disease: Shift to palliative systemic therapy

---

Important Questions to Ask Your Oncology Team

Since YOUR specific situation requires your doctor's evaluation based on your complete medical picture, here are key questions to guide your conversation:

1. Is my cancer resectable (can it be surgically removed)? What factors influence this decision?

2. Am I medically fit for major surgery? What tests or evaluations will determine this?

3. What chemotherapy regimen do you recommend, and why? (Common regimens include FOLFOX or CAPEOX)

4. Should my tumor be tested for MSI-H/dMMR status? If positive, should I consider immunotherapy?

5. What is the treatment timeline? How long will chemotherapy last before surgery, and how long after?

6. What are the expected side effects, and how will we manage them?

7. What imaging and follow-up will I need after treatment?

---

Key Biomarkers Your Doctor May Test

According to NCCN Guidelines, universal testing is recommended for:

• Microsatellite Instability (MSI) or Mismatch Repair (MMR) status — determines if immunotherapy might be beneficial
• PD-L1 status — helps predict response to certain immunotherapies
• HER2 status — relevant for advanced/metastatic disease
• CLDN18.2 — emerging biomarker for advanced disease

---

Why This Approach Works

The combination of chemotherapy before surgery plus surgery plus additional therapy has been shown to improve outcomes compared to surgery alone. The chemotherapy:

• Shrinks the tumor, making surgery more complete
• Treats cancer cells that may have already spread microscopically
• Improves overall survival rates

Your oncologist will determine the most appropriate approach for YOUR case based on your tumor characteristics, overall health, and preferences.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.